A Novel Polymorphism in Exon 10 of the Factor V Gene Inducing an Amino Acid Replacement of Arginine to Lysine at Codon 485

Tetsuo Ozawa; Kenji Niiya; Naoko Ejiri; Nobuo Sakuragawa

doi:10.1055/s-0038-1665424

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1997; 78(05): 1419-1420
DOI: 10.1055/s-0038-1665424

Letter to the Editor

Schattauer GmbH Stuttgart

A Novel Polymorphism in Exon 10 of the Factor V Gene Inducing an Amino Acid Replacement of Arginine to Lysine at Codon 485

Tetsuo Ozawa

The Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Toyama City, Japan

,

Kenji Niiya

The Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Toyama City, Japan

,

Naoko Ejiri

The Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Toyama City, Japan

,

Nobuo Sakuragawa

The Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Toyama City, Japan

› Author Affiliations

Abstract

PDF Download

PDF (406 kb)

References

References
1 Dahlbäck B, Carlsson MS, vensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
2 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Driven RJ, de Ronde, van derVeldenPA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
3 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
4 Takamiya O, Ishida F, Kodaira H, Kitano K. APC resistance and the Mnl I genotype (Gln506) of coagulation factor V are rare in Japanese population. Thromb Haemost 1995; 74: 996
5 Ozawa T, Niiya K, Sakuragawa N. Absence of factor V Leiden in the Japanese. Thromb Res 1996; 81: 595-596
6 Shen NL, Fan ST, Pyati J, Graff R, LaPolla RJ, Edgington TS. The serine protease cofactor facto V is synthesized by lymphocytes. J Immunol 1993; 150: 2992-3001
7 Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994; 343: 1361-1362
8 Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 1987; 84: 4846-4850
9 Kane WH, Davie EW. Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. Proc Natl Acad Sci USA 1986; 83: 6800-6804
10 Kane WH, Ichinose A, Hagen FS, Davie EW. Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry 1987; 26: 6508-6514
11 Cripe LD, Moore KD, Kane WH. Structure of the gene for human coagulation factor V. Biochemistry 1992; 31: 3777-3785